Igroseles

Atenolol and chlortalidone, the active ingredients in Igroseles, are a beta‑blocker and a thiazide‑like diuretic presented as an oral tablet for oral use. They are prescribed to manage hypertension in adult patients, helping to lower both systolic and diastolic blood pressure. Igroseles is marketed in the European Union and complies with EU pharmaceutical standards.

GNH USA supplies Igroseles as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Igroseles, a combination antihypertensive, is used to treat conditions related to elevated blood pressure.

- Essential hypertension: lowers systolic and diastolic pressure to target levels. - Isolated systolic hypertension: provides effective control, especially in older adults. - Hypertensive patients with fluid retention: combines beta‑blockade and diuresis to improve overall blood pressure management.

Common Side Effects: - Dizziness: mild to moderate light‑headedness, especially after standing. - Fatigue: general tiredness or reduced energy levels. - Cold extremities: reduced blood flow to hands and feet. - Increased urination: due to diuretic effect of chlortalidone. - Electrolyte imbalance: mild changes in potassium or sodium levels. - Gastrointestinal discomfort: occasional nausea or abdominal pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Significant electrolyte disturbances: pronounced hypokalemia or hyponatremia. - Renal impairment: worsening kidney function in susceptible individuals. - Allergic reactions: rash, itching, or swelling of face and throat. - Bradycardia: abnormally slow heart rate. - Pancreatitis: rare inflammation of the pancreas.

Patients should be monitored regularly while using Igroseles.

- Monitor blood pressure: ensure readings stay within therapeutic targets. - Assess renal function: check creatinine and eGFR before and during therapy. - Check electrolyte levels: especially potassium and sodium, due to diuretic effect. - Use caution in asthma: β1‑selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Igroseles may interact with several other medicines.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - NSAIDs: may reduce antihypertensive efficacy and affect renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced hypotensive effect. - Antidiabetic agents: possible masking of hypoglycemia symptoms. - Calcium channel blockers: may increase risk of bradycardia. - Antidepressants (e.g., SSRIs): potential for increased blood pressure variability.